Andreas Plückthun

Andreas Plückthun (born May 7, 1956) is a scientist whose research is focused on the field of protein engineering. Andreas Plückthun is the director of the department of biochemistry at the University of Zurich. Plückthun was appointed to the faculty of the University of Zurich as a Full professor of biochemistry in 1993. Plückthun was group leader at the Max Planck Institute of Biochemistry, Germany (1985-1993). He was elected to the European Molecular Biology Organization (EMBO) in 1992, and named a member of the German National Academy of Science (Leopoldina) in 2003. He is cofounder of the biotechnology companies Morphosys (Martinsried, Germany) Molecular Partners AG (Zürich-Schlieren, Switzerland) and G7 Therapeutics. (Zürich-Schlieren, Switzerland).

Plückthun is a member of the board directors of the Antibody Society.

His work is highly cited in the field of antibody engineering. He has been honoured by a number of international awards. Provided by Wikipedia
Showing 1 - 10 results of 10 for search 'Andreas Plückthun', query time: 0.05s Refine Results
  1. 1
    Directed evolution for high functional production and stability of a challenging G protein-coupled receptor
    Get full text
    article
    Save to List
    Saved in:
  2. 2
    Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists
    Get full text
    article
    Save to List
    Saved in:
  3. 3
    Asymmetric requirement of Dpp/BMP morphogen dispersal in the Drosophila wing disc
    Get full text
    article
    Save to List
    Saved in:
  4. 4
    Apoptosis-inducing anti-HER2 agents operate through oligomerization-induced receptor immobilization
    Get full text
    article
    Save to List
    Saved in:
  5. 5
    Intermolecular biparatopic trapping of ErbB2 prevents compensatory activation of PI3K/AKT via RAS–p110 crosstalk
    Get full text
    article
    Save to List
    Saved in:
  6. 6
    A survival selection strategy for engineering synthetic binding proteins that specifically recognize post-translationally phosphorylated proteins
    Get full text
    article
    Save to List
    Saved in:
  7. 7
    Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation
    Get full text
    article
    Save to List
    Saved in:
  8. 8
    Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control
    Get full text
    article
    Save to List
    Saved in:
  9. 9
    Engineering an anti-HER2 biparatopic antibody with a multimodal mechanism of action
    Get full text
    article
    Save to List
    Saved in:
  10. 10
    Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization
    Get full text
    article
    Save to List
    Saved in:
Search Tools: Get RSS Feed — Email this Search — Save Search